Indivior Pharmaceuticals (INDV) has announced the pricing of its offering of $450M in convertible senior notes due in 2031. The offering size was increased from an initial amount of $400M.

CRISPR Therapeutics AG (Nasdaq: CRSP) (the “Company”) today announced its intention to offer, subject to market conditions and other factors, $350 million aggregate principal amount of its convertible ...

Honeywell International Inc. HON shares are down in Wednesday’s premarket after the company priced a senior notes offering as part of its strategy to spin off its aerospace segment. The offering ...

NEW YORK--(BUSINESS WIRE)--Blackstone (NYSE: BX) priced its offering of $600 million of 4.300% senior notes due 2030 and $600 million of 4.950% senior notes due 2036 of Blackstone Reg Finance Co.

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) today announced private placement offerings of $1.5 billion in aggregate principal amount of new senior secured first lien notes due ...